Balcerzak, M. (2013). Zagadnienia nanotechnologii w prawie, Czy nanotechnologia może czerpać z doświadczeń biotechnologii? [The issues of nanotechnologies in law, Is nanotechnology can draw on the expertise of biotechnology?]. In D. M. Trzmielak (Ed.), Innowacje i komercjalizacja w biotechnologii [Innovation and commercialization in biotechnology], Poznań - Łodź, Poland: Uniwerstytet Łodzki.
Baran, A. (2015). Prawne aspekty nanotechnologii w kontekście ochrony środowiska [Legal aspects of nanotechnology in environmental protection, Economics and Environment]. Ekonomia i Środowisko, 1(52), 28-40.
Bazela, M. (2008). Jakie są największe wyzwania w dzisiejszej bioetyce? [What are the biggest challenges in today’s bioethics?]. Retrieved from http://biotechnologia.pl/bioetyka/aktualnosci/jakie-sa-najwieksze-wyzwania-w-dzisiejszej-bioetyce-maciej-bazela,11197
Commission Recommendation of 7 February 2008 on a code of conduct for responsible nanosciences and nanotechnologies research C(2008) 424 (OJ L 2008/116/46, 30.04.2008).
Communication from the Commission of 2 February 2000 on the precautionary principle (COM(2000) 1final - Not published in the Official Journal, 2.02.2000).
Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use (OJ L 311, 28.11.2001).
Dorocki, S., & Kula, A. (2015). Przestrzenne zrożnicowanie nanotechnologii w Europie [Spatial diversity of development nanotechnology in Europe]. Prace Komisji Geografii Przemysłu Polskiego Towarzystwa Geograficznego, 29(1), 27-41.
EC/726/2004 Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (OJ L 136, 30.04.2004).
Falkner, R., Breggin, L., Jaspers, N., Pendergrass, J., & Porter, R. D. (2010). International coordination and cooperation: the next agenda in nanomaterials regulation. In G. A. Hodge, D. M. Bowman, & A. D.10.4337/9781849808125.00033
Jurewicz, M. (2014). Nanotechnologia, Regulacje prawne, Legislacja Unii Europejskiej [Nanotechnology, Regulations, European Union Legislation]. Warszawa, Poland: Difin.
Maliszewska-Mazur, M. (2010). Nanotechnologia - nowe wyzwania, nowe możliwości i nowe problemy [Nanotechnology - new challenges, new possibilities and new problems]. Ochrona Środowiska i Zasobów Naturalnych, 45, 153-161.
Mapping study on regulation and governance of nanotechnologies (2009). Retrieved from http://www.nanowerk.com/nanotechnology/reports/reportpdf/report126.pdf
Marchant, G. E., & Doug, J. S. (2006). Transnational Models for Regulation of Nanotechnology. Journal of Law, Medicine & Ethics, 714-725. Retrieved from http://caat.jhsph.edu/programs/workshops/Transnational%20models%20for%20reg.pdf10.1111/j.1748-720X.2006.00091.x
Oud, M. (2007). A European perspective. In G. A. Hodge, D. M. Bowman, & K. Ludlow (Eds.), New global frontiers in regulation, The age of nanotechnology (pp. 97-109). Cheltenham and Northampton, Great Britain: Edward Elgar Publishing.
Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (Text with EEA relevance), (OJ L 342, 22.12.2009).
Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorization and Restriction of Chemicals (OJ L 396, 30.12.2006).
Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making available on the market and use of biocidal products (OJ L 167, 27.06.2012).
Sandler, R. (2009). Nanotechnology: The Social and Ethical Issues. Woodrow Wilson International Center for Scholars, Project on Emerging Nanotechnologies, PEN 16.
Scientific Committee on Emerging and Newly Identified Health Risks (2009). Risk Assessment of Products of Nanotechnologies. Retrieved from http://ec.europa.eu/health/ph_risk/committees/04_scenihr/docs/scenihr_o_023.pdf
Szponder, D. K. (2010). Nanomateriały w środowisku - korzyści zagrożenia [Nanomaterials in the environment - benefits and risks]. V Krakowska Konferencja Młodych Uczonych. Krakow, Poland.
The Regulation (EC) No 1272/2008 of the European Parliament and of the Council of 16 December 2008 on classification, labelling and packaging of substances and mixtures (OJ L 353, 31.12.2008).
Witek, R. (2014). Czy patentowanie może być niemoralne? [Is patenting may be immorial?]. Retrieved from http://wtspatent.pl/wp-content/uploads/2014/05/pl4.pdf
Zapor, L. (2012). Bezpieczeństwo i higiena pracy a rozwoj nanotechnologii [Occupational safety and health and nanotechnology, Occupational Safety, Science and Practice]. Bezpieczeństwo Pracy: nauka i praktyka, 1, 4-7.